Barclays PLC Chemo Centryx, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
SELL
$22.17 - $51.8 $9.56 Million - $22.3 Million
-430,999 Reduced 78.78%
116,113 $6 Million
Q2 2022

Aug 12, 2022
BUY
$15.36 - $27.51 $7.76 Million - $13.9 Million
505,000 Added 1199.18%
547,112 $13.6 Million
Q1 2022

May 16, 2022
SELL
$22.22 - $39.12 $2.42 Million - $4.27 Million
-109,104 Reduced 72.15%
42,112 $1.06 Million
Q4 2021

Feb 14, 2022
BUY
$18.38 - $40.5 $420,295 - $926,113
22,867 Added 17.82%
151,216 $5.51 Million
Q3 2021

Nov 09, 2021
BUY
$13.18 - $19.83 $620,263 - $933,219
47,061 Added 57.89%
128,349 $2.2 Million
Q2 2021

Aug 13, 2021
SELL
$9.59 - $50.88 $135,842 - $720,715
-14,165 Reduced 14.84%
81,288 $1.09 Million
Q1 2021

May 13, 2021
BUY
$49.53 - $68.4 $3.88 Million - $5.35 Million
78,280 Added 455.83%
95,453 $4.89 Million
Q4 2020

Feb 11, 2021
SELL
$47.25 - $65.16 $3.14 Million - $4.33 Million
-66,454 Reduced 79.46%
17,173 $1.06 Million
Q3 2020

Nov 12, 2020
BUY
$46.35 - $61.69 $2.37 Million - $3.16 Million
51,152 Added 157.51%
83,627 $4.58 Million
Q2 2020

Aug 12, 2020
BUY
$38.58 - $65.07 $728,158 - $1.23 Million
18,874 Added 138.77%
32,475 $1.87 Million
Q1 2020

May 13, 2020
SELL
$32.73 - $50.78 $956,272 - $1.48 Million
-29,217 Reduced 68.24%
13,601 $548,000
Q4 2019

Feb 10, 2020
SELL
$6.81 - $39.55 $125,065 - $726,335
-18,365 Reduced 30.02%
42,818 $1.69 Million
Q3 2019

Nov 14, 2019
SELL
$6.47 - $8.96 $137,532 - $190,462
-21,257 Reduced 25.78%
61,183 $414,000
Q2 2019

Aug 14, 2019
BUY
$8.31 - $14.85 $576,099 - $1.03 Million
69,326 Added 528.64%
82,440 $767,000
Q1 2019

May 15, 2019
BUY
$10.01 - $13.89 $72,552 - $100,674
7,248 Added 123.56%
13,114 $182,000
Q4 2018

Feb 14, 2019
SELL
$9.15 - $12.26 $86,357 - $115,709
-9,438 Reduced 61.67%
5,866 $63,000
Q3 2018

Nov 14, 2018
BUY
$10.49 - $13.72 $71,489 - $93,501
6,815 Added 80.28%
15,304 $194,000
Q2 2018

Aug 14, 2018
SELL
$10.62 - $13.98 $48,607 - $63,986
-4,577 Reduced 35.03%
8,489 $112,000
Q1 2018

May 15, 2018
BUY
$5.9 - $14.99 $50,863 - $129,228
8,621 Added 193.95%
13,066 $178,000
Q4 2017

Feb 14, 2018
BUY
$5.53 - $8.42 $14,820 - $22,565
2,680 Added 151.84%
4,445 $26,000
Q3 2017

Nov 14, 2017
BUY
$6.5 - $10.69 $11,472 - $18,867
1,765
1,765 $13,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email